on The Vanguard Group, Inc. (isin : US12572Q1058)
The Vanguard Group's Position on Mural Oncology plc
The Vanguard Group, Inc. has disclosed its position in Mural Oncology plc related to the Irish Takeover Panel's rules. As of September 11, 2025, The Vanguard Group holds 771,251 ordinary shares, accounting for 4.47% of the relevant securities.
No additional parties to the offer are disclosed by The Vanguard Group, and there are no cash-settled or stock-settled derivatives associated. The disclosed dealings include purchasing 16 shares and selling 48 shares at a price of $2.07 per share.
No indemnity or option agreements have been made to influence dealings, and no agreements or understandings regarding voting rights of securities related to options or derivatives exist.
R. E.
Copyright © 2025 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all The Vanguard Group, Inc. news